Pelosi G, Pasini F, Bresaola E, Bogina G, Pederzoli P, Biolo S, Menard S, Zamboni G
Institute of Pathology, Ospedale Civile Maggiore, Verona, Italy.
J Pathol. 1997 Sep;183(1):62-9. doi: 10.1002/(SICI)1096-9896(199709)183:1<62::AID-PATH1095>3.0.CO;2-A.
Cell-surface high-affinity monomeric 67-kD laminin receptors have been proposed to promote the invasion and metastasis of a variety of tumours, but there are, as yet, no data regarding the expression of these molecules in pancreatic endocrine tumours (PETs). The prognosis of these very rare tumours is problematic and the only irrefutable evidence of their malignancy still continues to be the occurrence of local invasion and metastases. In this retrospective investigation, 34 functioning and 48 non-functioning sporadic PETs were evaluated for the expression of the MLuC5 monoclonal antibody, which specifically recognizes the 67-kD laminin receptors. Laminin receptors were found in 42/82 cases (51 per cent) and their expression was associated with metastatic disease (P < 0.001), high proliferative activity expressed by a Ki-67 index above 5.0 per cent (P < 0.001), absence of progesterone receptors (P = 0.013), immunoreactivity for hormones other than insulin (P < 0.001), a tumour diameter more than 3.0 cm (P = 0.001), and a fatal clinical outcome (P < 0.001). Laminin receptors were also expressed by most metastatic foci and all intravascular emboli of tumour cells. Positivity for laminin receptors was associated with shorter survival in functioning (P = 0.026) and non-functioning (P = 0.042) tumours, as well as in the whole series of pancreatic endocrine tumours (P < 0.001). On multivariate analysis, laminin receptor expression was not an independent prognostic factor, while a Ki-67 index above 5.0 per cent was the most powerful predictor of survival. However, the association of laminin receptor expression and Ki-67 index could identify a group of malignant PETs with low proliferative activity characterized by an intermediate prognosis. In conclusion, these data suggest that monomeric laminin receptors may play a role in the invasion and metastasis of PETs and that their expression may be an additional prognostic factor, along with proliferative activity.
细胞表面高亲和力单体67-kD层粘连蛋白受体被认为可促进多种肿瘤的侵袭和转移,但目前尚无关于这些分子在胰腺内分泌肿瘤(PETs)中表达的数据。这些非常罕见的肿瘤预后存在问题,其恶性的唯一确凿证据仍然是局部侵袭和转移的发生。在这项回顾性研究中,对34例功能性和48例非功能性散发性PETs进行了评估,检测其对特异性识别67-kD层粘连蛋白受体的MLuC5单克隆抗体的表达。在82例病例中有42例(51%)发现了层粘连蛋白受体,其表达与转移性疾病相关(P < 0.001)、Ki-67指数高于5.0%所表达的高增殖活性相关(P < 0.001)、无孕激素受体(P = 0.013)、对胰岛素以外的激素有免疫反应性(P < 0.001)、肿瘤直径大于3.0 cm(P = 0.001)以及致命的临床结局相关(P < 0.001)。大多数转移灶和所有肿瘤细胞的血管内栓子也表达层粘连蛋白受体。层粘连蛋白受体阳性与功能性肿瘤(P = 0.026)、非功能性肿瘤(P = 0.042)以及整个胰腺内分泌肿瘤系列(P < 0.001)的生存期较短相关。多因素分析显示,层粘连蛋白受体表达不是一个独立的预后因素,而Ki-67指数高于5.0%是生存的最有力预测指标。然而,层粘连蛋白受体表达与Ki-67指数的联合可识别出一组具有低增殖活性、预后中等的恶性PETs。总之,这些数据表明单体层粘连蛋白受体可能在PETs的侵袭和转移中起作用,并且其表达可能是一个与增殖活性一起的额外预后因素。